TCL Archive In Brief: David Feigal To Head FDA’s Antiviral Division; ODAC To Discuss Melphalan, Amifostine NDAs January 17, 1992
TCL Archive In Brief: PHS Established Two Scientific Integrity Offices; Workshop On Ethical Issues Planned August 18, 1989
TCL Archive NCI Grant Funding: “Zone of Likelihood” Moves From 7th to 9th Percentile November 30, 2012
TCL Archive European regulators plan more rigorous rules for accelerated approval in cancer. November 11, 2005
TCL Archive FDA Oncologic Drug Committee Agrees That “Kitty Fight” With NCI Should Be Negotiated November 28, 1975
